Peter W. Dini, Ph.D.

Peter W. Dini, Ph.D.

Partner

Tel. 617.994.0861
Fax 617.742.4214
Email: pdini@lahive.com

Background

Education

  • State University of New York at Albany, B.S., 1985
  • State University of New York at Stony Brook, M.A., 1988; Ph.D., 1993
  • Suffolk University Law School, J.D., 2003

Bar & Court Admissions

  • Massachusetts Bar
  • U.S. Supreme Court
  • U.S. District Court, District of Massachusetts
  • U.S. Patent and Trademark Office

Professional Involvement

  • American Association for the Advancement of Science
  • American Bar Association
  • American Intellectual Property Law Association
  • Boston Patent Law Association
  • Massachusetts Bar Association

Honors & Awards

  • Massachusetts Super Lawyers® Rising Star List 2008, 2009

Practice Areas

Life Sciences, Litigation, Patents

Industry & Technical Focus

Biotechnology, Chemistry, Pharmaceuticals, Antibodies, RNAi

Practice Description

Dr. Dini specializes in patent counseling and strategic planning, including patent prosecution, freedom to operate evaluations, opinion work, and due diligence analyses involving a variety of biotechnologies. He has extensive knowledge in the areas of cellular and molecular biology, biochemistry, genomics, protein chemistry, gene therapy, immunology, RNAi, vaccines, and therapeutic antibodies, and represents a broad range of clients, from start-up biotechnology companies to established biopharmaceutical corporations.

Peter’s doctoral research examined the role of oncogenes in leukemia and his post-doctoral research, conducted at Stanford University and at Harvard Medical School, examined genetic mechanisms in hematopoiesis using embryonic stem cells.

Notable Experience

  • Conducting an IP due diligence review of a biotech start-up for a syndicate of venture capital firms involved in a multi-million dollar financing.
  • Representing a venture capital firm in evaluating the IP of a Swiss-based drug discovery company prior to a multi-million dollar financing round.
  • Serving as U.S. patent counsel to a Swiss-based drug discovery company.
  • Representing a privately-held biotechnology company in preparing its IP portfolio prior to its multi-million dollar acquisition by one of the world’s leading research-based pharmaceutical companies.
  • Conducting, for a Japan-headquartered pharmaceutical company, an IP due diligence review of an antibody discovery company in preparation for its multi-million dollar acquisition.

Publications & Speaking Engagements

  • Panelist, "Biological Sequences: Do’s and Don’ts For Freedom-To-Operate and Patentability Searches," Boston Patent Law Association (BPLA), May 7, 2009.
  • Speaker, “On Antibodies…From Market Developments to Patent Protection,” for a group of European patent attorneys in Switzerland, February 2009.
  • Speaker, “How Secure is your IP?” at TiE Ottawa, Canada, June 24, 2008.
  • Speaker, “What Else Can I Do With My Advanced Degree Beyond Academia and Industry?” presented to graduate students at Boston University Medical School.
  • Author of research articles in the Journal of Molecular and Cellular Biology and the Journal of Virology.

 

Case studies

 
 
Our Thinking Expands Yours

The client, a start-up biotech company, licensed technology related to gene therapy from a research university, with the objective of commercializing the technology worldwide. » read more

News & Events

Confidentiality Agreements - When "Standard" Is Not So Standard » read more

Jeanne DiGiorgio and Maneesh Gulati presenting at the AUTM 2010 Annual Meeting » read more

Patent Strategy Update: Court Curtails Extraterritorial Scope of Method Patents » read more

March 20, 2010
Jeanne DiGiorgio and Maneesh Gulati present, "Patent Prosecution Strategies: Issues, Considerations and Solutions" » read more

Web Site Developed by  Neptune Web, Inc.